Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Looking Back: Compensation keeps rising | Major recalls | FDA approves new cholesterol pill | ACC shares DOAC recommendations
Monday, August 3, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

The Month in Review

Cardiologist compensation keeps rising—but are we nearing a tipping point?

Many cardiologists are earning more in 2026 than they did in 2025. However, there is a fear that compensation and wRVUs can only climb so far in this current healthcare environment before things start to stall. 

READ MORE >
physician money payments dollars
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist compensation keeps rising—but are we nearing a tipping point?

Share on Twitter Share on Facebook Share on Linkedin
physician money payments dollars
Many cardiologists are earning more in 2026 than they did in 2025. However, there is a fear that compensation and wRVUs can only climb so far in this current healthcare environment before things start to stall. 
READ MORE >

Medtronic recalls thousands of cannulae due to risk of leaks

More than 50,000 devices are being recalled due to pinhole leaks associated with multiple risks. Customers should return any unused cannulae to Medtronic.

READ MORE >
fda medical device recall
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls thousands of cannulae due to risk of leaks

Share on Twitter Share on Facebook Share on Linkedin
fda medical device recall
More than 50,000 devices are being recalled due to pinhole leaks associated with multiple risks. Customers should return any unused cannulae to Medtronic.
READ MORE >

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 

READ MORE >
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Share on Twitter Share on Facebook Share on Linkedin

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Share on Twitter Share on Facebook Share on Linkedin
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 
READ MORE >

FDA approves first cholesterol pill of its kind

Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first cholesterol pill of its kind

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.
READ MORE >

Steerable sheaths for PFA recalled due to safety risk

More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 

READ MORE >
FDA recall medical device recall product recall
Share on Twitter Share on Facebook Share on Linkedin

Steerable sheaths for PFA recalled due to safety risk

Share on Twitter Share on Facebook Share on Linkedin
FDA recall medical device recall product recall
More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 
READ MORE >

ACC takes on DOAC use with new scientific statement

Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.

READ MORE >
Rivaroxaban (Xarelto) is among the direct oral anticoagulants (DOACs) including in the new 2026 ACC consensus statement on the use of DOACs.
Share on Twitter Share on Facebook Share on Linkedin

ACC takes on DOAC use with new scientific statement

Share on Twitter Share on Facebook Share on Linkedin
Rivaroxaban (Xarelto) is among the direct oral anticoagulants (DOACs) including in the new 2026 ACC consensus statement on the use of DOACs.
Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.
READ MORE >

Medtronic recalls heart valve delivery system due to safety risk

The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.

READ MORE >
Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls heart valve delivery system due to safety risk

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]
The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.
READ MORE >

Heart surgeon makes history, performs first robotic procedure of its kind

A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair.

READ MORE >
Rakesh M. Suri, MD, DPhil, Corewell Health William Beaumont University Hospital
Share on Twitter Share on Facebook Share on Linkedin

Heart surgeon makes history, performs first robotic procedure of its kind

Share on Twitter Share on Facebook Share on Linkedin
Rakesh M. Suri, MD, DPhil, Corewell Health William Beaumont University Hospital
A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair.
READ MORE >

Recall update: FDA now urging clinicians to return vascular device linked to 3 deaths

Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.

READ MORE >
alert FDA recall safety warning
Share on Twitter Share on Facebook Share on Linkedin

Recall update: FDA now urging clinicians to return vascular device linked to 3 deaths

Share on Twitter Share on Facebook Share on Linkedin
alert FDA recall safety warning
Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.
READ MORE >

Heartflow launches new AI-powered staging tool for coronary plaque assessments

In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 

READ MORE >
Heartflow's Plaque Analysis AI-driven software that automtically assesses the coronary arteries, maps them and adds markers for areas of interest with plaque.
Share on Twitter Share on Facebook Share on Linkedin

Heartflow launches new AI-powered staging tool for coronary plaque assessments

Share on Twitter Share on Facebook Share on Linkedin
Heartflow's Plaque Analysis AI-driven software that automtically assesses the coronary arteries, maps them and adds markers for areas of interest with plaque.
In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Why new pediatric valve is a breakthrough | FDA's warning after death | Heart surgeon compensation | AI for cardiology questions
Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup